Stefano D'errico

Dr. Stefano D'errico

University of Naples Federico II - Department of Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2011 in Analytical Chemistry
Verified
Journal Article
Closed access
Giulia RuscianoGiulia Rusciano
Giulia Rusciano
Anna Chiara De LucaAnna Chiara De Luca
Anna Chiara De Luca
GPGiuseppe Pesce
Giuseppe Pesce
ASAntonio Sasso
Antonio Sasso
Giorgia OlivieroGiorgia Oliviero
Giorgia Oliviero
LMLuciano Mayol
Luciano Mayol

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FAFelice Amato
Felice Amato
Rossella TomaiuoloRossella Tomaiuolo
Rossella Tomaiuolo
FNFabrizia Nici
Fabrizia Nici
Nicola BorboneNicola Borbone
Nicola Borbone
Ausilia ElceAusilia Elce
Ausilia Elce
GCGiuseppe Castaldo
Giuseppe Castaldo
Computational techniques, and in particular molecular dynamics (MD) simulations, have been successfully used as a complementary technique to predict and analyse the structural behaviour of nucleic acids, including peptide nucleic acid- (PNA-) RNA hybrids. This study shows that a 7-base long PNA complementary to the seed region of miR-509-3p, one of the miRNAs involved in the posttranscriptional regulation of the CFTR disease-gene of Cystic Fibrosis, and bearing suitable functionalization at its N- and C-ends aimed at improving its resistance to nucleases and cellular uptake, is able to revert the expression of the luciferase gene containing the 3′UTR of the gene in A549 human lung cancer cells, in agreement with the MD results that pointed at the formation of a stable RNA/PNA heteroduplex notwithstanding the short sequence of the latter. The here reported results widen the interest towards the use of small PNAs as effective anti-miRNA agents.

19 November 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Nicola BorboneNicola Borbone
Nicola Borbone
MBMariarosaria Bucci
Mariarosaria Bucci
Giorgia OlivieroGiorgia Oliviero
Giorgia Oliviero
EMElena Morelli
Elena Morelli
Jussara AmatoJussara Amato
Jussara Amato
MSMaria Scuotto
Maria Scuotto

11 January 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Maria MarzanoMaria Marzano
Maria Marzano
Andrea Patrizia FalangaAndrea Patrizia Falanga
Andrea Patrizia Falanga
daniela marascodaniela marasco
daniela marasco
Nicola BorboneNicola Borbone
Nicola Borbone
Stefano D'erricoStefano D'errico
Stefano D'errico
Giorgia OlivieroGiorgia Oliviero
Giorgia Oliviero
ε-poly-l-Lysine (ε-PLL) peptide is a product of the marine bacterium Bacillus subtilis with antibacterial and anticancer activity largely used worldwide as a food preservative. ε-PLL and its synthetic analogue α,ε-poly-l-lysine (α,ε-PLL) are also employed in the biomedical field as enhancers of anticancer drugs and for drug and gene delivery applications. Recently, several studies reported the interaction between these non-canonical peptides and DNA targets. Among the most important DNA targets are the DNA secondary structures known as G-quadruplexes (G4s) which play relevant roles in many biological processes and disease-related mechanisms. The search for novel ligands capable of interfering with G4-driven biological processes elicits growing attention in the screening of new classes of G4 binders. In this context, we have here investigated the potential of α,ε-PLL as a G4 ligand. In particular, the effects of the incubation of two different models of G4 DNA, i.e., the parallel G4 formed by the Pu22 (d[TGAGGGTGGGTAGGGTGGGTAA]) sequence, a mutated and shorter analogue of the G4-forming sequence known as Pu27 located in the promoter of the c-myc oncogene, and the hybrid parallel/antiparallel G4 formed by the human Tel22 (d[AGGGTTAGGGTTAGGGTTAGGG]) telomeric sequence, with α,ε-PLL are discussed in the light of circular dichroism (CD), UV, fluorescence, size exclusion chromatography (SEC), and surface plasmon resonance (SPR) evidence. Even though the SPR results indicated that α,ε-PLL is capable of binding with µM affinity to both the G4 models, spectroscopic and SEC investigations disclosed significant differences in the structural properties of the resulting α,ε-PLL/G4 complexes which support the use of α,ε-PLL as a G4 ligand capable of discriminating among different G4 topologies.

Verified
Journal Article
Open access
PDF file
FPFilippo Prencipe
Filippo Prencipe
AZAnna Zanfardino
Anna Zanfardino
MNMichela Di napoli
Michela Di napoli
FRFilomena Rossi
Filomena Rossi
Stefano D'erricoStefano D'errico
Stefano D'errico
Diego TesauroDiego Tesauro
Diego Tesauro
The evolution of antibacterial resistance has arisen as the main downside in fighting bacterial infections pushing researchers to develop novel, more potent and multimodal alternative drugs.Silver and its complexes have long been used as antimicrobial agents in medicine due to the lack of silver resistance and the effectiveness at low concentration as well as to their low toxicities compared to the most commonly used antibiotics. N-Heterocyclic Carbenes (NHCs) have been extensively employed to coordinate transition metals mainly for catalytic chemistry. However, more recently, NHC ligands have been applied as carrier molecules for metals in anticancer applications. In the present study we selected from literature two NHC-carbene based on acridinescaffoldand detailed nonclassicalpyrazole derived mono NHC-Ag neutral and bis NHC-Ag cationic complexes. Their inhibitor effect on bacterial strains Gram-negative and positivewas evaluated. Imidazolium NHC silver complex containing the acridine chromophore showed effectiveness at extremely low MIC values. Although pyrazole NHC silver complexes are less active than the acridine NHC-silver, they represent the first example of this class of compounds with antimicrobial properties. Moreover all complexesare not toxic and they show not significant activity againstmammalian cells (Hek lines) after 4 and 24 h. Based on our experimental evidence, we are confident that this promising class of complexes could represent a valuable starting point for developing candidates for the treatment of bacterial infections, delivering great effectiveness and avoiding the development of resistance mechanisms.

20 July 2007 in Organic Letters
Verified
Journal Article
Closed access
Annalisa GuaragnaAnnalisa Guaragna
Annalisa Guaragna
Stefano D'erricoStefano D'errico
Stefano D'errico
Daniele D'AlonzoDaniele D'Alonzo
Daniele D'Alonzo
Silvana PedatellaSilvana Pedatella
Silvana Pedatella
GPGiovanni Palumbo
Giovanni Palumbo